Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
110 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP)----1件: 13 💬
215 mg fampridine-SR (4-aminopyridine, 4-AP)----1件: 13 💬
320 mg fampridine-SR (4-aminopyridine, 4-AP)----1件: 13 💬
44-aminopyridine----2件: 3, 13 💬
5Dalfampridine
(4-Aminopyridine)
1件: Dalfampridine (4-Aminopyridine)1件: Dalfampridine (4-Aminopyridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 4, 13 💬
6Dalfampridine 10 MG [Ampyra]
(4-Aminopyridine)
1件: Dalfampridine (4-Aminopyridine)1件: Dalfampridine (4-Aminopyridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
7Dalfampridine ER
(4-Aminopyridine)
1件: Dalfampridine (4-Aminopyridine)1件: Dalfampridine (4-Aminopyridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
8Dalfampridine ER, 10 Mg Oral Tablet, Extended Release
(4-Aminopyridine)
1件: Dalfampridine (4-Aminopyridine)1件: Dalfampridine (4-Aminopyridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
9Dalfampridine-ER 10mg
(4-Aminopyridine)
1件: Dalfampridine (4-Aminopyridine)1件: Dalfampridine (4-Aminopyridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
10Dalfampridine-ER 5mg
(4-Aminopyridine)
1件: Dalfampridine (4-Aminopyridine)1件: Dalfampridine (4-Aminopyridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
11Other: Dalfampridine plus physical therapy
(4-Aminopyridine)
1件: Dalfampridine (4-Aminopyridine)1件: Dalfampridine (4-Aminopyridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
12Other: Withdrawal of dalfampridine-ER 10mg
(4-Aminopyridine)
1件: Dalfampridine (4-Aminopyridine)1件: Dalfampridine (4-Aminopyridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
13Sustained-release oral dalfampridine
(4-Aminopyridine)
1件: Dalfampridine (4-Aminopyridine)1件: Dalfampridine (4-Aminopyridine) 💬 7件: KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
5件: Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬